International Immunopharmacology

12.4k papers and 250.7k indexed citations i.

About

The 12.4k papers published in International Immunopharmacology in the last decades have received a total of 250.7k indexed citations. Papers published in International Immunopharmacology usually cover Immunology (4.9k papers), Molecular Biology (4.5k papers) and Oncology (1.8k papers) specifically the topics of Immune Response and Inflammation (1.2k papers), Immune Cell Function and Interaction (1.1k papers) and Inflammasome and immune disorders (726 papers). The most active scholars publishing in International Immunopharmacology are Jong Soon Kang, Sang‐Bae Han, Sheikh F. Ahmad, Fengping Shan and Ahmed Nadeem.

In The Last Decade

Fields of papers published in International Immunopharmacology

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in International Immunopharmacology. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in International Immunopharmacology

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in International Immunopharmacology. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in International Immunopharmacology with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025